Shefali Shah

Global Vp, Market Value And Commercial Effectiveness at MindMaze

Shefali Shah, MBA, has a diverse and extensive work experience spanning over 25 years. Shefali currently holds the position of Global VP, Market Value and Commercial Effectiveness at MindMaze since April 2022. Prior to that, they served as the VP, Commercial Effectiveness at Huma from October 2021 to April 2022, where they played a key role in driving US-based commercial operations and strategy.

In 2020, Shefali held the position of Director, Medical Strategy and Value Communication at GSK, where they led the successful launch strategy and engagement plan for Benlysta, the first product approved to treat Lupus Nephritis. Shefali collaborated with global and US-based teams to ensure access to major payors based on a strong scientific story.

From 2018 to 2020, Shefali worked as a Principal, Global Market Access Consulting at Evidera, where they supported clients in making key commercialization decisions, including M&A evaluations, optimizing clinical trial design, and developing value and evidence for access, reimbursement, and pricing.

Shefali joined Novo Nordisk in 2011 and held various roles including Director, Market Access Effectiveness, Director, Field Planning and Insights, and Associate Director, Field Management Analytics until 2018. Shefali contributed to the company's market access strategies and field management analytics.

Before joining Novo Nordisk, Shefali worked at inVentiv Health as Director, Specialty & Biotech Practice, Managed Markets from 2009 to 2011. Shefali also worked at Strategyx, an inVentiv Health company, as an Associate Director from 2008 to 2009 and at Strategyx as a Consultant from 2007 to 2008.

Shefali started their career as a Senior Manager at Wyeth Consumer Healthcare from 2002 to 2006. Shefali also worked as a Consultant at PwC Consulting from 1997 to 2002.

Throughout their career, Shefali has demonstrated expertise in commercial effectiveness, market access, strategic planning, and consulting, contributing to the success of various organizations in the healthcare industry.

Shefali Shah, MBA, pursued their education at NYU Stern School of Business from 2002 to 2006, where they obtained a Master of Business Administration (MBA) with a focus on Marketing and Finance. Prior to that, from 1991 to 1995, they attended Columbia University, where they earned a Bachelor of Science (BS) degree in Electrical Engineering. Shefali also holds an additional certification as a RYS Certified Yoga Instructor with 500 hours of training, obtained from an institution that specifically certifies yoga instructors.

Links

Previous companies

Huma logo
Pfizer logo
Novo Nordisk logo

Timeline

  • Global Vp, Market Value And Commercial Effectiveness

    April, 2022 - present

View in org chart